|
Please be patient, it may take 1 to 2 minutes for pages to load.
NSC-100,NSC-24 CORAL CALCIUM as low as $19.95
Fungal
Defense
TEACHING
MATERIALS:
|
Cancer, the Immune System and Beta Glucan
What is Cancer and How Does It
Attack the Body? The second most common cause of death in the U.S. is cancer, accounting for 1 in 5 deaths with anticipation to increase to 2 in 5 in the year 2,000. But what is cancer? Cancer is any of a group of more than 100 diseases which symptoms are unrestrained growth of cells in one of the body organs or tissues. The fact is you probably get cancer up to six times per year, but your immune system when at peak destroys the cancerous cells before growth and multiplication! When not destroyed immediately by your immune system, the cancer-invaded cells deviate from the usual controls over cell growth. The growth begins when the genes controlling cell growth and multiplication (oncogenes) are transformed by cancer-causing agents known as carcinogens. After a cell has a malignant transformation, the small group of abnormal cells divide more rapidly than the normal surrounding cells. The abnormal cells usually show a lack of "differentiation," meaning they no longer perform the specialized task of their host tissue. Thus, the cancerous cells are in fact parasites avoiding control of hormones and nerves and consuming nutrients while contributing nothing. This rapid multiplication results in invasion and destruction of other body cells. These cancerous cells can then spread (metastasize) via the bloodstream and lymphatic system to other parts of the body from their original site. A cancer differs from a benign (non-dangerous) tumor in two ways: cancers grow, spread and infiltrate the tissues around them, in addition to spreading to form new tumors that grow independently. Cancerous tumors develop and multiply when the immune system surveillance team fails to identify the cancerous cell invaders and then is overwhelmed when recognition does occur, due to the massive number of corrupted cancer cells that have multiplied rapidly when undetected and unchecked. We are our own worst enemies in that we first suppress our immune systems with excessive free radicals, or rogue molecules, that damage cells due to the impact of toxins on our systems. Polluted air, water, fast food; in addition to pathogens such as parasites, fungi, bacteria and viruses joined with heavy metals and toxic chemicals, assault us daily. Genetic factors join immunological weakness in certain cancer cases. The most common treatment in 50% of cases is chemotherapy, but success occurs in only a few cases (2 to 25%), such as ovarian cancer in women and testicular cancer in men, in addition to Duke's C, a form of colon cancer. The logical question to ask would be, if chemotherapy has such a low rate of success, why is it used so often? Dr. Ralph Moss, author of Questioning Chemotherapy, explains that most people confuse decreased tumor size with disappearance of disease. The association appears logical, but no known proof exists to support the connection. It is troubling that alternative therapies are often criticized for not being tested according to scientific standards, but many "accepted" treatments, including chemotherapy, have only limited success and little correlation between tumor shrinkage and patient survival. The answer unfortunately often appears to be economics, with chemotherapy treatments frequently costing six figures. We must understand the facts, which are often difficult to accept in the midst of such suffering and fear for life caused by these dreaded cancer diseases. How Beta 1,3/1,6 Glucan Nutritionally Fights Back Against Cancer & Aids Chemotherapy The most common form of cancer is carcinoma which originates in the skin, or in the glandular tissue such as the breast or prostate gland. Another form of cancer, sarcoma, affects connective and supportive tissue such as bone, muscle, cartilage and fat. Still another type are melanomas which are skin cancers. Lymphomas affect the lymphatic system, while leukemias are cancers of the blood-forming organs. The inability of the immune system to first recognize and then to appropriately respond to cancer tumors is a major contributing factor to the ability of the disease to multiply and spread before recognition by the body. Good news! The immune response can be potentiated to more ably recognize the cancer attempting to hide in normal cells by a naturally occurring biomolecule named Beta 1,3/1,6 glucan. A particularly potent immune potentiator is an insoluble particulate Beta 1,3/1,6 glucan extracted and purified from Baker's yeast (no harmful yeast proteins remain that cause an allergic reaction). Beta glucan is a non-toxic nutritional biomolecule classified G.R.A.S. by the FDA, that significantly potentiates the macrophage, the large white immune cell; increasing its ability to recognize cancerous cells, particularly as we age. According to research by Peter Mansell, Donald Carrow, M.D., Nicholas DiLuzio, D.L. Williams, M.L. Patchen and others at Harvard, Baylor, Tulane, the Armed Services Radiobiology Research Institute and a multitude of other scientific research centers, Beta glucan extracted from yeast cell wall enhances immune system awareness of the cancerous cells and nutritionally aids in control. When boosted by Beta glucan, the immune alarm to activate the entire immune response is sounded against the cancer, enabling the macrophages to attack the cancerous cells with enhanced cytotoxic granules (toxic chemicals) that kill the cancer cell and prevent further multiplication and spreading. Results have been particularly dramatic in breast, sarcoma and melanoma cancers. The research demonstrates Beta 1,3/1,6 glucan, particularly in small particle sizes (micronized) for better absorption and more rapid response, increases protection of the immune cells from the damage of radiation treatments and then, after treatments, enhances recovery of platelets and white immune cells. The macrophage is also enhanced to more ably and rapidly remove the toxic debris (phagocytosis) created by radiation and chemotherapy in the body, thus reducing or eliminating the negative side effects such as nausea, hair loss, inability to sleep and skin radiation injury. Beta 1,3/1,6 glucan in NSC-24 Immunition(tm) products is micronized and purified in a proprietary process to provide maximum potentiation of the macrophage immune cell with minimum amounts. Science demonstrates particulate Beta glucan can nutritionally enable your immune response to fight back against cancer, reduce or eliminate the negative side effects of many treatments, and, as an adjuvant, make chemotherapy treatments more effective than acting alone. Cancer affects us all and we must now utilize all available science to provide answers. Nature has provided Beta glucan; science has demonstrated the benefits; now we must begin using this incredible biomolecule for potentiating the immune response not only to fight cancer, but the legion of pathogens that attempt to rob us of good health daily. Cancer - Carcinoma of the Breast: Mansell P.W.A., Ichinose H., Reed R.J., Krements E.T., McNamee R.B., Di Luzio N.R.; "Macrophage-mediated Destruction of Human Malignant Cells in Vitro". Journal of National Cancer Institute; 54: 571-580. 1975. Quote: "The initial 9 patients studied had malignant carcinoma of the breast. Control and experimental lesions were injected; subsequently biopsies were performed at varying intervals for histologic evaluation. Always when glucan or glucan and RF fraction were administered intra-lesionally, the size of the lesion was strikingly reduced in as short a period as 5 days. ...In small lesions, resolution was complete, whereas in large lesions, resolutions was partial." Cancer - Melanoma: DiLuzio N.R. Williams D.L. et al, "Comparative evaluation of the tumor inhibitory and antibacterial activity of solubilized and particulate glucan," Recent Results Cancer Res 75:165-172. 1980.* Quote: "Intravenous administration of soluble or particulate glucan resulted in significant reduction in the growth of a syngeneic anaplastic mammary carcinoma and melanoma B16 and enhanced survival." Cancer - Sarcoma and Melanoma: Williams DL, et al, "Therapeutic efficacy of glucan in a murine model of hepatic metastatic disease," Hepatology 5(2):198-206. Mar 1985.* Quote: "...coincubation of particulate glucan with diverse populations of normal or tumor cells in vitro indicated that glucan exerted a direct cytostatic effect on sarcoma and melanoma cells and, in contrast, had a proliferative effect on normal spleen and bone marrow cells." Cancer : Carrow, D.J.; "Beta-1,3-glucan as a Primary Immune Activator," Townsend Letter; June 1996. Quote: "Over the past 11 months I have been able to convince five out of eight breast cancer patients who were undergoing radiation therapy, to consume one capsule of beta 1,3/1,6 glucan (NSC-24 3 mg) three times per day. To date, I have observed that none of the patients using NSC-24 have suffered from any type of radiation injury to the skin, while the three patients who chose not to use NSC-24 all show signs of extensive radiation damage to the skin." Hemopoietic Stimulation: Patchen M.L., McVittie T.J.; Temporal Response of Murine Pluripotent Stem Cells and Myeloid and Erythroid Progenitor Cells to Low-dose Glucan Treatment. Acta Hemat; 70:281-288. Experimental Hematology Dept, Armed Forces Radiobiology Research Insti, Bethesda, MD. 1983. Quote: "Clearly, there are numerous possible uses for an agent such as glucan, which is a potent stimulator of hemopoietic [formation of blood cells] activity. Currently, we [U.S. Armed Services] are using glucan to enhance hemopoietic proliferation in conjunction with hemopoietic injury induced by radiation." Platelet and White Blood Cell Recovery: Pachen ML, MacVittie TJ, "Comparative effects of soluble and particulate glucans on survival in irradiated mice," J Biol Response Mod 5(1):45-60. Experimental Hematology Dept, Armed Forces Radiobiology Research Inst, Bethesda, MD. Feb 1986. Quote: "Both glucan-P and glucan-F enhanced the recovery of peripheral blood white cell numbers, platelet numbers, and hematocrit values. In addition, both agents increased endogenous pluripotent hemopoietic stem cell numbers in sublethally irradiated mice." About the Author Frank M. Jordan is a noted author, lecturer, formulator and researcher on (eta-glucan from yeast cell wall. Jordan received a degree in graduate studies from The University of Texas at Austin and serves as President of Carmel Research, Inc., a pioneer for more than two decades in Beta glucan research with major medical schools.
© Reprinted Permission of Macrophage Technologies, Inc. (MTI) Copyright © 1998 by Nutritional Supply Corporation. Reproduction of this document by any means without prior written permission is strictly prohibited.
Copyright 2001.....Property of Best Natural Health Solutions
|
